Yiqun Han
- Oncology top 10%
- HER2/EGFR in Cancer Research 16
- Cancer Treatment and Pharmacology 10
- Lung Cancer Research Studies 8
- Cancer Immunotherapy and Biomarkers 7
-
- Breast Cancer Treatment Studies 14
- Cancer Genomics and Diagnostics 4
-
- Advanced Breast Cancer Therapies 13
-
- Breast Lesions and Carcinomas 5
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yiqun Han
41 papers receiving 565 citations
Peers
Comparison fields: 5 of 71
- Oncology 369
- Cancer Research 116
- Radiology, Nuclear Medicine and Imaging 117
- Pharmaceutical Science 25
- Pulmonary and Respiratory Medicine 133
Countries citing papers authored by Yiqun Han
This map shows the geographic impact of Yiqun Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqun Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqun Han more than expected).
Fields of papers citing papers by Yiqun Han
This network shows the impact of papers produced by Yiqun Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqun Han. The network helps show where Yiqun Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yiqun Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 23 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 13 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 1 | |
| 15 | 2022 | 44 | |
| 16 | 2021 | 2 | |
| 17 | 2021 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2020 | 8 |
About Yiqun Han
Yiqun Han is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 576 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Breast Cancer Treatment Studies (14 papers), Advanced Breast Cancer Therapies (13 papers), Cancer Treatment and Pharmacology (10 papers), Lung Cancer Research Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Breast Lesions and Carcinomas (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Oncology (369 citations), Cancer Research (116 citations) and Radiology, Nuclear Medicine and Imaging (117 citations). Yiqun Han has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Binghe Xu, Renée A. Harrison, Roma D. Williams, Jiayu Wang, Pin Zhang, Fei Ma, Yang Luo, Qiao Li, Ruigang Cai and Shanshan Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.